Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes

• Published in: Nephrology, dialysis, transplantation dialysis, transplantation, 1991, Vol.6 (6), p.428-434
• Main Authors: SEYFERT, U. T, HELMLING, E, HAUCK, W, SKROCH, D, ALBERT, W
• Format: Article
• Language: English
• Subjects: Acrylic Resins; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biocompatible Materials; Biological and medical sciences; Blood Coagulation - drug effects; Cellulose - analogs & derivatives; Emergency and intensive care: renal failure. Dialysis management; Female; Humans; Intensive care medicine; Interleukin-2 - analysis; Male; Medical sciences; Membranes, Artificial; Platelet Aggregation - drug effects; Renal Dialysis
• ISSN: 0931-0509; 1460-2385

Clotting within the dialyser is one of the most significant clinical parameters of biocompatibility. A study was designed to evaluate the biocompatibility of two different dialysis membranes (cuprophane and polyacrylonitrile) during therapy with conventional heparin. Transient leukopenia during cuprophane but not during polyacrylonitrile haemodialysis was observed, and elastase release using polyacryonitrile membranes was reduced (P less than 0.001). An elevation in F VIII:C activity during cuprophane haemodialysis has to be taken as an indication of endothelial disturbances. There was a significant (P less than 0.001) platelet activation (beta-thromboglobulin) and combined thrombin/plasmin generation using cuprophane membranes. This new synthetic polyacrylonitrile membrane inactivates the clotting in an extracorporeal system to a sufficient degree and allows a reduction in dosages of heparin. Platelet activation, platelet turnover, disturbances of endothelium, fibrinolysis activation, and granulocyte activation are reproducible parameters of a described interaction model. They also permit a comparison of different haemodialysis membranes.